These findings indicated that Ct-HBx-dependent ablation of RhoGDIα and CAPZB through MAZ may be one of major reasons underlying the decreased expressions of RhoGDIα and CAPZB in hepatoma cells. Here, MAZ is linked to hepatocellular carcinoma.